Article

DXEK has direct effect on corneal hysteresis & biomechanics

Descemetorhexis with endokeratoplasty (DXEK) has a direct effect on corneal hysteresis and the biomechanical properties of the human cornea.

Descemetorhexis with endokeratoplasty (DXEK) has a direct effect on corneal hysteresis and the biomechanical properties of the human cornea, according to Thomas John and colleagues from Loyola University, Chicago, USA.

In this first report on corneal hysteresis and corneal resistance factor following sutureless corneal graft, i.e. DXEK, surgery, 12 eyes of 12 DXEK patients (group1) and 88 eyes of 44 age-matched normal subjects (group 2) were studied. All DXEK subjects were operated on by a single surgeon and the donor corneal disks were surgeon-cut, using the microkeratome and artificial anterior chamber (Moria). None of the eyes had anterior corneal slits to the host-donor interface and all subjects underwent corneal biomechanical evaluation with the Reichert ocular response analyser (ORA).

It was discovered that ORA corneal hysteresis measurements were significantly lower in the DXEK patients (6.94±1.65) than in normal subjects (10.51±1.22). DXEK also had a direct effect on the biomechanical properties of the human cornea, as evidenced by the corneal resistance factor measurements (group1: 8.60±2.10 versus group 2: 9.86±1.23).

The researchers stated that this was the first report of corneal hysteresis and corneal resistance factor following DXEK surgery.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.